MARKOV MODEL-BASED ECONOMIC EVALUATION OF COMBINATION THERAPY WITH EZETIMIBE AND STATIN MONOTHERAPY

被引：0
|
作者：
Pan, D. [1 ]
机构：
[1] Fudan Univ, Shanghai 200433, Peoples R China
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.260
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV35
引用
收藏
页码：A761 / A761
页数：1
相关论文
共 50 条
  • [41] Myopathy induced by statin-ezetimibe combination: Evaluation of potential risk factors
    Brahmachari, Ballari
    Chatterjee, Suparna
    INDIAN JOURNAL OF PHARMACOLOGY, 2015, 47 (05) : 563 - 564
  • [42] Markov model of decision analysis for monotherapy in rheumatoid arthritis: Duration of therapy and economic aspects
    Goryachev, DV
    Erdesz, S
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 536 - 536
  • [43] Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or Contraindications A Markov Model
    Ara, Roberta
    Pandor, Abdullah
    Tumur, Indra
    Paisley, Suzy
    Duenas, Alejandra
    Williams, Robert
    Rees, Angie
    Wilkinson, Anna
    Durrington, Paul
    Chilcott, Jim
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2008, 8 (06) : 419 - 427
  • [44] Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or ContraindicationsA Markov Model
    Roberta Ara
    Abdullah Pandor
    Indra Tumur
    Suzy Paisley
    Alejandra Duenas
    Robert Williams
    Angie Rees
    Anna Wilkinson
    Paul Durrington
    Jim Chilcott
    American Journal of Cardiovascular Drugs, 2008, 8 : 419 - 427
  • [45] The upfront lipid-lowering combination therapy of statins and ezetimibe vs statin monotherapy in the reduction of cardiovascular outcomes. A meta-analysis.
    Banach, M.
    Jaiswal, V
    Ang, S. P.
    Sawhney, A.
    Deb, N.
    Penson, P.
    Toth, P.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [46] High-intensity statin monotherapy versus moderate-intensity statin plus ezetimibe therapy: Effects on vascular biomarkers
    Ferreira, C. E. S.
    Franca, C. N.
    Izar, M. C. O.
    Camargo, L. M.
    Roman, R. M.
    Fonseca, F. A. H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 180 : 78 - 79
  • [47] Comparative Effectiveness of Moderate-Intensity Statin With Ezetimibe Combination Therapy Versus High-Intensity Statin Monotherapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study
    Jang, Ji-Yong
    Kim, Seonji
    Cho, Jaehyeong
    You, Seng Chan
    Kim, Jung-Sun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B62 - B62
  • [48] Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
    Daniel Tobias Michaeli
    Julia Caroline Michaeli
    Tobias Boch
    Thomas Michaeli
    Clinical Drug Investigation, 2022, 42 : 643 - 656
  • [49] C-REACTIVE PROTEIN (CRP) AND LDL-CHOLESTEROL RESPONSE TO EZETIMIBE MONOTHERAPY AND TO EZETIMIBE ADDED-ON TO BASELINE STATIN THERAPY
    Pearson, T.
    Ballantyne, C.
    Veltri, E.
    Shah, A.
    Bird, S.
    Lin, J.
    Rosenberg, E.
    Tershakovec, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 187 - 187
  • [50] Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
    Michaeli, Daniel Tobias
    Michaeli, Julia Caroline
    Boch, Tobias
    Michaeli, Thomas
    CLINICAL DRUG INVESTIGATION, 2022, 42 (08) : 643 - 656
12345